Visualizing Human Telomerase Activity with Primer-Modified Au Nanoparticles
Jiasi Wang
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorLi Wu
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorJinsong Ren
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorCorresponding Author
Xiaogang Qu
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China.Search for more papers by this authorJiasi Wang
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorLi Wu
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorJinsong Ren
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Search for more papers by this authorCorresponding Author
Xiaogang Qu
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China
Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Laboratory of Chemical Biology, Graduate School of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China.Search for more papers by this authorAbstract
Telomerase is over-expressed in over 85% of all known human tumors. This renders the enzyme a valuable biomarker for cancer diagnosis and an important therapeutic target. The most widely used telomeric repeat amplification protocol (TRAP) assay has been questioned for telomerase detection. It is reported that human telomerase activity can be visualized by using primer-modified Au nanoparticles. The working principle is based on the elongated primers conjugated to the gold nanoparticle (AuNP) surface, which can fold into a G-quadruplex to protect the AuNPs from the aggregation. The developed simple and sensitive colorimetric assay can measure telomerase activity down to 1 HeLa cell µL−1. More importantly, this assay can be easily extended to high-throughput and automatic format. The AuNP-TS method is PCR-free and therefore avoids the amplification-related errors and becomes more reliable to evaluate telomerase activity. This assay has also been used for initial screening of telomerase inhibitors as anticancer drug agents.
References
- 1 a) E. H. Blackburn, Nature 1991, 350, 569; b) M. D. Stone, M. Mihalusova, C. M. O'Connor, R. Prathapam, K. Collins, X. Zhuang, Nature 2007, 446, 458.
- 2 a) J. W. Shay, S. Bacchetti, Eur. J. Cancer 1997, 33, 787; b) J. W. Shay, W. E. Wright, Cancer Cell 2002, 2, 257; c) N. W. Kim, M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, J. W. Shay, Science 1994, 266, 2011.
- 3 a) A. De Cian, G. Cristofari, P. Reichenbach, E. De Lemos, D. Monchaud, M. P. Teulade-Fichou, K. Shin-Ya, L. Lacroix, J. Lingner, J. L. Mergny, Proc. Natl. Acad. Sci. USA 2007, 104, 17347; b) G. Krupp, K. Kuhne, S. Tamm, W. Klapper, K. Heidron, A. Rott, R. Parwaresch Nucleic Acids Res. 1997, 25, 919.
- 4 a) W. E. Wright, J. W. Shay, M. A. Piatyszek, Nucleic Acids Res. 1995, 23, 3794–3795; b) D. Gomez, J. L. Mergny, J. F. Rious, Cancer Res. 2002, 62, 3365; c) J. Reed, M. Gunaratnam, M. Beltran, A. P. Reszka, R. Vilar, S. Neidle, Anal. Biochem. 2008, 380, 99; d) Y Xiao, K. Y. Dane, T. Uzawa, A. Csordas, J. Qian, H. T. Soh, P. S. Daugherty, E. T. Lagally, A. J. Heeger, K. W. Plaxco, J. Am. Chem. Soc. 2010, 132, 15299.
- 5 a) Y. Xiao, V. Pavlov, T. Niazov, A. Dishon, M. Kotler, I. Willner, J. Am. Chem. Soc. 2004, 126, 7430; b) T. Niazov, V. Pavlov, Y. Xiao, R. Gill, I. Willner, Nano Lett. 2004, 4, 1683; c) R. Freeman, E. Sharon, C. Teller, A. Henning, Y. Tzfati, I. Willner, ChemBioChem. 2010, 11, 2362; d) C. Ding, X. Li, Y. Ge, S. Zhang, Anal. Chem. 2010, 82, 2850.
- 6 a) E. Sharon, R. Freeman, M. Riskin, N. Gil, Y. Tzfati, I. Willner, Anal. Chem. 2010, 82, 8390; b) Y. Li, B. Liu, X. Li, Q. Wei, Biosens. Bioelectron. 2010, 25, 2543; c) W. Yang, X. Zhu, Q. Liu, Z. Lin, B. Qiu, G. Chen, Chem. Commun. 2011, 47, 3129.
- 7 a) J. Grimm, J. M. Perez, L. Josephson, R. Weissleder, Cancer Res. 2004, 64, 639; b) G. Zheng, W. L. Daniel, C. A. Mirkin, J. Am. Chem. Soc. 2008, 130, 9644; c) X. Zhou, D. Xing, D. Zhu, L. Jia, Anal. Chem. 2009, 81, 255.
- 8 a) R. Elghanian, J. J. Storhoff, R. C. Mucic, R. L. Letsinger, C. A. Mirkin, Science 1997, 277, 1078; b) J. Liu, Y. Lu, Nat. Protoc. 2006, 1, 246; c) D. Li, A. Wieckowska, I. Willner, Angew. Chem. Int. Ed. 2008, 47, 3927.
- 9 a) C. Chen, C. Zhao, X. Yang, J. Ren, X. Qu, Adv. Mater. 2010, 22, 389; b) F. Xia, X. Zuo, R. Yang, Y. Xiao, D. Kang, A. Vallée-Bélisle, X. Gong, J. D. Yuen, B. B. Hsu, A. J. Heeger, K. W. Plaxco. Proc. Natl. Acad. Sci. USA 2010, 107, 10837; c) X. Wang, L. Wu, J. Ren, D. Miyoshi, N. Sugimoto, X. Qu, Biosens. Bioelectron 2011, 26, 4804; d) J. Geng, K. Qu, J. Ren, X. Qu, Mol. BioSyst. 2010, 6, 2389; e) X. Xie, W. Xu, T. Li, X. Liu, Small 2011, 7, 1393.
- 10 W. Zhao, W. Chiuman, J. C. Lam, S. A. McManus, W. Chen, Y. Cui, R. Pelton, M. A. Brook, Y. Li, J. Am. Chem. Soc. 2008, 130, 3610.
- 11 a) E. Izbicka, R. T. Wheelhouse, E. Raymond, K. K. Davidson, R. A. Lawrence, D. Sun, B. E. Windle, L. H. Hurley, D. D. Von Hoff, Cancer Res. 1999, 59, 639; b) H. Han, D. R. Langley, A. Rangan, L. H. Hurley, J. Am. Chem. Soc. 2001, 123, 8902.
- 12 a) A. M. Zahler, J. R. Williamson, T. R. Cech, D. M. Prescott, Nature 1991, 350, 718; b) A. J. Zaug, E. R. Podell, T. R. Cech Proc. Natl. Acad. Sci. USA 2005, 102, 10864.
- 13 a) H. Yu, X. Wang, M. Fu, J. Ren, X. Qu, Nucleic Acids Res. 2008, 36, 5695; b) H. Yu, C. Zhao, Y. Chen, M. Fu, J. Ren, X. Qu, J. Med. Chem. 2010, 53, 492; c) C. Zhao, J. Geng, L. Feng, J. Ren, X. Qu, Chem. Eur. J. 2011, 17, 8209.
